Ameritas Investment Partners, Inc. - SUMMIT THERAPEUTICS INC ownership

SUMMIT THERAPEUTICS INC's ticker is SMMT and the CUSIP is 86627T108. A total of 54 filers reported holding SUMMIT THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 0.27 and the average weighting 0.0%.

Quarter-by-quarter ownership
Ameritas Investment Partners, Inc. ownership history of SUMMIT THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$17,894
-25.5%
9,5690.0%0.00%0.0%
Q2 2023$24,018
+500.4%
9,569
+443.1%
0.00%
Q1 2022$4,000
-20.0%
1,7620.0%0.00%
Q4 2021$5,000
-44.4%
1,7620.0%0.00%
Q3 2021$9,000
-30.8%
1,7620.0%0.00%
Q2 2021$13,0001,7620.00%
Other shareholders
SUMMIT THERAPEUTICS INC shareholders Q3 2021
NameSharesValueWeighting ↓
Virtus ETF Advisers LLC 50,714$94,8350.06%
Baker Brothers Advisors 3,140,473$5,872,6850.03%
VANCE WEALTH, INC. 39,266$73,4270.03%
CSS LLC/IL 258,814$483,9820.03%
SHELL ASSET MANAGEMENT CO 317,240$5930.02%
Steward Partners Investment Advisory, LLC 650,000$1,215,5000.02%
Alpine Global Management, LLC 30,000$56,1000.01%
HoyleCohen, LLC 74,408$139,1430.01%
BENDER ROBERT & ASSOCIATES 24,059$44,9900.01%
SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC 86,212$161,2160.01%
View complete list of SUMMIT THERAPEUTICS INC shareholders